March 28, 2022
UC San Diego Health receives “LGBTQ+ Healthcare Equality Leader” designation by the Human Rights Campaign Foundation for policies and practices dedicated to the equitable treatment and inclusion of LGBTQ+ patients, visitors and employees.
September 22, 2023
UC San Diego Health is recognized by Vizient as 2023 Birnbaum Quality Leadership Top Performer for the fifth consecutive year.
September 3, 2020
UC San Diego Health is the first hospital in San Diego and only health care system in Southern California to transplant a liver from a donor with Human Immunodeficiency Virus (HIV) into an HIV-positive recipient. The surgery is part of a national clinical trial.
July 10, 2024
The grant from The Leukemia & Lymphoma Society will fund research on the affordability and utilization of fertility preservation with health insurance for adolescent young adults with blood cancers.
September 16, 2022
UC San Diego study finds housing instability linked to increased mortality risk in cancer, highlighting need to screen for patients’ social risk factors
March 16, 2023
On Match Day, March 17, members of this year’s School of Medicine graduating class will discover where they will serve their residencies. The next generation of California physicians is nothing if not passionate about leading a new era in medicine.
February 5, 2024
UC San Diego Health’s artificial intelligence-powered predictive health care solutions are advancing patient care
September 26, 2011
UC San Diego Health System is proud to receive the 2011 UHC Quality Leadership Award. This national award is given to academic medical centers that demonstrate excellence in delivering high-quality care as measured by the UHC Quality & Accountability Study, which has been conducted by the consortium annually since 2005.
February 8, 2023
With a generous $22 million in gifts from Joan and Irwin Jacobs, UC San Diego Health will bring its Center for Health Innovation into full reality.
October 2, 2020
Patients receiving care for advanced cancer at Moores Cancer Center at UC San Diego Health were more likely to survive or experience a longer period without their disease progressing if they received personalized cancer therapy.
